norfloxacin and imipenem, anhydrous

norfloxacin has been researched along with imipenem, anhydrous in 49 studies

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-199015 (30.61)18.7374
1990's7 (14.29)18.2507
2000's17 (34.69)29.6817
2010's8 (16.33)24.3611
2020's2 (4.08)2.80

Authors

AuthorsStudies
Dumas, JL; Köhler, T; Reinhardt, A; Ricou, B; Rohner, P; van Delden, C; Wood, P1
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N1
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R1
Brazas, MD; Breidenstein, EB; Hancock, RE; Overhage, J1
Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K1
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L1
Cattoir, V; Nordmann, P; Poirel, L1
Berçot, B; Nordmann, P; Poirel, L1
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C1
Chevalier, J; Davin-Regli, A; Dupont, M; Lavigne, JP; Pagès, JM; Sotto, A; Tran, QT1
Bartolomé, R; Coelho, A; González-López, JJ; Larrosa, MN; Lavilla, S; Prats, G1
Espinal, P; Gibert, I; Marti, S; Martínez, P; Roca, I; Vila, J1
Gebreyes, WA; Rajamohan, G; Srinivasan, VB1
Courvalin, P; Coyne, S; Guigon, G; Périchon, B1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A1
Anderson, KC; Kellogg, GE; Sarkar, A1
Gao, F; Huang, G; Xiao, J1
Aubert, G; Dorche, G; Pozzetto, B1
Fukuda, H; Hashimoto, H; Hirai, K; Iyobe, S; Jakics, EB1
Fallara, A; Ravaoarinoro, M; Toma, E1
Fukuda, H; Hirai, K; Hosaka, M; Iyobe, S1
Rahal, K1
Renneberg, J; Walder, M1
Björnegård, B; Brorson, JE; Trollfors, B; Zackrisson, G1
Klastersky, J; Van der Auwera, P1
Weinstein, MP1
Bailer, R; Chu, DT; Fernandes, PB; Hanson, CW; Stamm, JM; Vojtko, C1
Ogle, JW; Reller, LB; Vasil, ML1
Gulden, H; Kern, W; Kurrle, E; Vanek, E1
Berlioux, J; Daguet, GL; Mugnier, P; Pasteau, C; Ygout, JF1
Bebear, C; Lafferriere, C; Noury, P; Quentin, C; Saivin, S1
Durgham, SM; Ishag, AJ; Shibl, AM1
Neu, HC1
Bebear, C; Laurent, C; Noury, P; Quentin, C; Saivin, S1
Brandimarte, C; Martino, P; Serra, P; Valente, B; Venditti, M1
Gadebusch, HH; Shungu, DL; Weinberg, E1
Ayers, LW; Barnishan, J; Fass, RJ1
Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ1
Kinoshita, S; Kumagai, S1
Chevalier, J; Eyraud, A; Malléa, M; Pagès, JM1
Chaves, J; del Carmen Conejo, M; Hernández, G; Joyanes, P; Martínez-Martínez, L; Pascual A, A; Perea, EJ1
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E1
Fukuda, H; Kawamura, Y1
Chumjan, W; Hajjar, E; Mahendran, KR; Schulte, A; Suginta, W; Weingart, H; Winterhalter, M1
Fallah, F; Goudarzi, M; Jahromi, MH; Karimi, A; Navidinia, M; Sajadi Nia, RS; Shiva, F1
Matar, GM; Nassar, FJ; Rahal, EA; Sabra, A1
Gonçalves de Souza, T; Karine de Sousa, A; Melo Coutinho, HD; Ribeiro-Filho, J; Rocha, JE; Sampaio de Freitas, T1
Akrami, S; Alkhudhairy, MK; Benyagoub, E; Raouf, FEA; Saki, M1
Abulreesh, HH; Ahmad, I; Aldosari, MS; Alshehri, WA; Arafa, SH; Asiri, FH; Elbanna, K; Obaid, NA; Organji, SR1

Reviews

3 review(s) available for norfloxacin and imipenem, anhydrous

ArticleYear
Current scenario of tetrazole hybrids for antibacterial activity.
    European journal of medicinal chemistry, 2019, Dec-15, Volume: 184

    Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles

2019
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl A

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin

1986
New antibiotics: areas of appropriate use.
    The Journal of infectious diseases, 1987, Volume: 155, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Ciprofloxacin; Enoxacin; Humans; Imipenem; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Thienamycins

1987

Other Studies

46 other study(ies) available for norfloxacin and imipenem, anhydrous

ArticleYear
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Humans; Longitudinal Studies; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections

2007
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal

2007
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins

2007
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Heat-Shock Proteins; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Protease La; Pseudomonas aeruginosa

2007
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence

2008
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey

2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids

2008
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Transformation, Bacterial

2008
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence

2009
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Bacterial Proteins; beta-Lactamases; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cefepime; Cephalosporinase; Cephalosporins; Drug Resistance, Bacterial; Enterobacter aerogenes; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests

2009
First detection of plasmid-encoded blaOXY beta-lactamase.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

    Topics: beta-Lactamases; Blotting, Southern; Child, Preschool; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction

2009
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol Resistance; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Tetracyclines

2009
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid

2009
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial

2010
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline

2010
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
    European journal of medicinal chemistry, 2012, Volume: 52

    Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics

2012
Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:3

    Topics: Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones

1992
Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11

    Topics: Carbenicillin; Chloramphenicol; Drug Resistance, Microbial; Genes, Bacterial; Gentamicins; Imipenem; Microbial Sensitivity Tests; Mutation; Norfloxacin; Phenotype; Plasmids; Pseudomonas aeruginosa; Transformation, Bacterial

1992
Inducible beta-lactamases in clinical isolates of non-aeruginosa Pseudomonas.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1992, Volume: 100, Issue:6

    Topics: beta-Lactamases; Cefazolin; Chloromercuribenzoates; Ciprofloxacin; Clavulanic Acids; Cloxacillin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Edetic Acid; Humans; Hydrolysis; Imipenem; Isoelectric Point; Molecular Weight; Norfloxacin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Spectrophotometry

1992
New norfloxacin resistance gene in Pseudomonas aeruginosa PAO.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:9

    Topics: Bacterial Outer Membrane Proteins; Cell Membrane; Chromosome Mapping; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Mutation; Norfloxacin; Permeability; Pseudomonas aeruginosa

1990
[Activity of cefotaxime and ceftriaxone and of imipenem, pefloxacin and norfloxacin on 13 species of bacteria].
    Archives de l'Institut Pasteur d'Algerie. Institut Pasteur d'Algerie, 1989, Volume: 57

    Topics: Bacteria; Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Species Specificity

1989
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:10

    Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Enterococcus faecalis; Escherichia coli; Female; Imipenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Norfloxacin; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus

1989
Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 15, Issue:5

    Topics: Amdinocillin; Anti-Bacterial Agents; Bordetella pertussis; Cinoxacin; Doxycycline; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Rifampin; Thienamycins

1985
Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
    Diagnostic microbiology and infectious disease, 1988, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Enoxacin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sepsis; Tobramycin

1988
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Anti-Infective Agents; Aztreonam; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Gentamicins; Haemophilus influenzae; Half-Life; Humans; Imipenem; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillins; Piperacillin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus; Thienamycins

1986
Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe.
    The Journal of infectious diseases, 1988, Volume: 157, Issue:4

    Topics: Ciprofloxacin; DNA, Bacterial; Drug Resistance, Microbial; Imipenem; Norfloxacin; Plasmids; Pseudomonas aeruginosa; Thienamycins

1988
In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.
    Chemotherapy, 1988, Volume: 34, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Interactions; Drug Resistance, Microbial; Humans; Imipenem; Norfloxacin; Ofloxacin; Oxazines; Thienamycins

1988
[Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
    Pathologie-biologie, 1988, Volume: 36, Issue:3

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Norfloxacin; Pefloxacin; Phenotype; Thienamycins

1988
In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Drugs under experimental and clinical research, 1987, Volume: 13, Issue:4

    Topics: Anti-Bacterial Agents; Drug Antagonism; Drug Interactions; Drug Synergism; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Thienamycins

1987
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin

1987
[In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
    Pathologie-biologie, 1987, Volume: 35, Issue:2

    Topics: Anti-Bacterial Agents; Drug Synergism; Fosfomycin; Humans; Imipenem; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus; Thienamycins

1987
N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa; Thienamycins

1985
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.
    Journal of clinical microbiology, 1984, Volume: 19, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Blood; Cefoxitin; Ceftazidime; Cephalosporins; Culture Media; Evaluation Studies as Topic; Humans; Imipenem; Moxalactam; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Sulfhydryl Compounds; Thienamycins; Urine

1984
Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:2

    Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Penicillins; Thienamycins

1995
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
    Diagnostic microbiology and infectious disease, 1996, Volume: 26, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin

1996
[Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:9

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Monobactams; Norfloxacin; Tetracycline; Thienamycins

1998
Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae.
    Biochemical and biophysical research communications, 2000, Aug-02, Volume: 274, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cell Membrane Permeability; Drug Resistance, Microbial; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norfloxacin

2000
[The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].
    Enfermedades infecciosas y microbiologia clinica, 2001, Volume: 19, Issue:9

    Topics: 4-Quinolones; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Resistance; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Spain

2001
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins

2001
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:3

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins

2002
Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain.
    Biochimica et biophysica acta, 2011, Volume: 1808, Issue:6

    Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ertapenem; Humans; Imipenem; Kinetics; Lipid Bilayers; Melioidosis; Meropenem; Models, Molecular; Molecular Sequence Data; Norfloxacin; Penicillin G; Phospholipids; Porins; Protein Conformation; Sequence Homology, Amino Acid; Thienamycins

2011
Determination of integron frequency by a polymerase chain reaction-restriction fragment length polymorphism method in multidrug-resistant Escherichia coli, which causes urinary tract infections.
    Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Imipenem; Integrons; Male; Microbial Sensitivity Tests; Norfloxacin; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Urinary Tract Infections; Uropathogenic Escherichia coli

2012
Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response.
    Foodborne pathogens and disease, 2013, Volume: 10, Issue:9

    Topics: Anti-Infective Agents; Azithromycin; DNA, Bacterial; Escherichia coli O157; Gene Expression Regulation, Bacterial; Genes, Bacterial; Gentamicins; Humans; Imipenem; Latex Fixation Tests; Microbial Sensitivity Tests; Norfloxacin; Prophages; Real-Time Polymerase Chain Reaction; Rifampin; Shiga Toxin; SOS Response, Genetics

2013
New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity.
    Microbial pathogenesis, 2018, Volume: 123

    Topics: Anti-Bacterial Agents; Antidepressive Agents; Bacteria; Drug Combinations; Drug Synergism; Erythromycin; Escherichia coli; Fluoxetine; Gentamicins; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Tetracycline

2018
Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia.
    Revista da Associacao Medica Brasileira (1992), 2022, Volume: 68, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; Humans; Imipenem; Iraq; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norfloxacin; Pneumonia

2022
Antimicrobial Resistance, Virulence Factor-Encoding Genes, and Biofilm-Forming Ability of Community-Associated Uropathogenic
    Polish journal of microbiology, 2022, Sep-01, Volume: 71, Issue:3

    Topics: Agar; Ampicillin; Animals; Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Ertapenem; Escherichia coli Infections; Female; Imipenem; Meropenem; Norfloxacin; Saudi Arabia; Sheep; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence Factors

2022